Lidia Mongay, MD PhD MBA, is a highly experienced professional in clinical development and medical strategy, currently serving as a Senior Clinical Development Leader at Bayer since November 2015. Prior roles include Global Clinical Leader at Novartis Oncology, where Lidia led a clinical team for hematology and solid tumor phases I-III trials, and Global Medical Director for Glivec/Tasigna. With extensive experience in market access, product launch, and medical consulting at both Novartis Oncology and Procter & Gamble, Lidia has significantly contributed to the strategic development and successful market implementation of pharmaceutical products. Academic qualifications include an MD in Immunology, a PhD in Cellular and Molecular Biology, and an MBA in Healthcare Management.
This person is not in the org chart
This person is not in any teams
This person is not in any offices